Endogenous Glucagon-Like Peptide-1 as a Potential Mediator of the Resolution of Diabetic Kidney Disease Following Roux en Y Gastric Bypass: Evidence and Perspectives

Advances in Endocrinology
doi 10.1155/2014/503846
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Excessive Weight Loss Following Laparoscopic Gastric Mini Bypass or Roux-En-Y Gastric Bypass Surgery

International Journal of Clinical Medicine
2016English

Psychological Predictors of Weight Loss Success Following Roux-En-Y Gastric Bypass

Current Research in Diabetes & Obesity Journal
2017English

Control of Hypertension After Roux-En-Y Gastric Bypass Among Obese Diabetic Patients

Arquivos de Gastroenterologia
Gastroenterology
2014English

Management of Failed Laparoscopic Roux-En-Y Gastric Bypass

Bariatric Surgical Patient Care
Surgical NursingNutritionMedicalSurgeryDietetics
2014English

Sleeve Gastrectomy Oder Roux-En-Y-Gastric-Bypass?

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
2019English

Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1-Stimulated Postprandial Insulin Secretion in Humans

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Early Postoperative Complications in Roux-En-Y Gastric Bypass

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
MedicineSurgeryGastroenterology
2016English

Roux-En-Y Gastric Bypass vs Gastric Banding for Morbid Obesity

Archives of Surgery
2012English

Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy